NEO

MKT CAP:$1B

NeoGenomics Inc

Market Cap

$1B

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$10.90-$0.86 (-7.31%)

Jun 5, 2026

52W High $13.2252W Low $4.84

Company Details

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutic...

CEO

—

IPO Date

Nov 2, 1999

Website

www.neogenomics.com

Key Metrics TTM

Revenue

$746M

+10.9% YoY

Net Income

-$99M

EPS (Diluted)

Free Cash Flow

-$5M

Revenue / Share

$28.88

Gross Margin

42.1%

Operating Margin

-13.9%

Net Margin

-13.3%

FCF Margin

-0.7%

P/S

1.8x

P/E

Earnings Reports

Q2 2026

Jul 28, 2026

PENDING

Q1 2026

Apr 28, 2026

$187M+11.1%

FY 2025

Feb 17, 2026

$727M+10.1%

Q4 2025

Feb 17, 2026

$190M+10.6%

Q3 2025

Oct 28, 2025

$188M+11.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee